Login/Sign Up
Vectibix 100 mg Infusion 5 ml is used to treat Metastatic colorectal cancer (mCRC). It contains Panitumumab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading. This medication may cause fetal harm when administered to a pregnant woman. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner become pregnant while undergoing therapy. Breastfeeding is not recommended while taking Panitumumab.
₹35154*
MRP ₹39060
10% off
₹35154*
MRP ₹39060
10% CB
₹3906 cashback(10%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
About Vectibix 100 mg Infusion 5 ml
Vectibix 100 mg Infusion 5 ml belongs to a class of monoclonal antibodies. It is used alone or with other anticancer medicines to treat wild-type RAS metastatic colorectal cancer (mCRC). Metastatic colorectal cancer (mCRC) is a type of cancer of the colon or rectum that has spread to other areas of the body.
Vectibix 100 mg Infusion 5 ml contains Panitumumab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading.
Vectibix 100 mg Infusion 5 ml will be administered under the supervision of a physician qualified by training and an experienced oncologist. The most frequent side effects of Vectibix 100 mg Infusion 5 ml when taken with other chemotherapy medications include diarrhea, paronychia (nail inflammation), fatigue, nausea, and diarrhea; stomatitis (oral mucosal inflammation and redness), mucosal inflammation, asthenia (abnormal physical weakness), anorexia, hypomagnesemia (an electrolyte disturbance), hypokalemia, rash, skin rash, itchiness, and dry skin.
Notify your doctor of any food or medication allergies or hypersensitivity reactions before taking the Vectibix 100 mg Infusion 5 ml. Vectibix 100 mg Infusion 5 ml may cause fetal harm when administered to a pregnant woman. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner become pregnant while undergoing therapy. Breastfeeding is not recommended while taking panitumumab.
Uses of Vectibix 100 mg Infusion 5 ml
Medicinal Benefits
Vectibix 100 mg Infusion 5 ml contains Panitumumab, a monoclonal antibody. It is used alone or in conjunction with other anticancer medications to treat metastatic colorectal cancer (mCRC). It works by slowing or preventing the growth of cancer cells. As a result, it inhibits the cancer from spreading.
Side Effects of Vectibix 100 mg Infusion 5 ml
Directions for Use
Storage
Drug Warnings
Before taking Vectibix 100 mg Infusion 5 ml, inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions. The dosage of this medicine will be based on your health condition. Your doctor may adjust your dose during therapy based on the treatment results. Vectibix 100 mg Infusion 5 ml may cause infusion reactions, interstitial lung disease (ILD), ocular toxicity, and dermatologic or soft tissue toxicity. Hence, inform the doctor immediately if you suffer any side effects. If therapy needs to be stopped, your doctor will make that decision. Vectibix 100 mg Infusion 5 ml is recommended not to be used in pregnant women. Therefore, if you become pregnant while on treatment with Panitumumab, tell your doctor immediately. Breastfeeding is not recommended while taking panitumumab. Alcohol should be avoided during treatment with this medicine. Drive only if alert, as the Vectibix 100 mg Infusion 5 ml may cause nausea or tiredness.
Therapeutic Class
Drug-Drug Interactions
Drug-Food Interactions
Diet & Lifestyle Advise
Habit Forming
How Vectibix 100 mg Infusion 5 ml Works
What if I have taken an overdose of Vectibix 100 mg Infusion 5 ml
Alcohol
Unsafe
Do not consume alcohol while on treatment with Vectibix 100 mg Infusion 5 ml.
Pregnancy
Unsafe
Vectibix 100 mg Infusion 5 ml is not recommended for use during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception for at least two months from the last dose of medicine to prevent pregnancy while taking these medications.
Breast Feeding
Unsafe
Do not breastfeed your baby during the period over which you are being treated with Vectibix 100 mg Infusion 5 ml and for two months after the last dose.
Driving
Caution
Vectibix 100 mg Infusion 5 ml will be administered to hospitalized patients. Hence, driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before taking Vectibix 100 mg Infusion 5 ml. Your doctor will weigh the benefits and potential risks before prescribing Vectibix 100 mg Infusion 5 ml.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before taking Vectibix 100 mg Infusion 5 ml. Your doctor may titrate the dose if required based on your condition.
Children
Caution
The safety and effectiveness of Vectibix 100 mg Infusion 5 ml in children have not been established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Keep Refrigerated. Do not freeze.Prepaid payment required.